Basic information
Biomarker: Langerhans cell
Full name: Langerhans cell
Clinical application: prognosis (favorable)
Histology type: endometrial carcinoma
Cohort characteristics
Country: USA
Region: South Florida
Followed up time : 46 months
| Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
|---|---|---|---|---|---|---|---|---|
| 50 | EEC | 50 |
Sample information
Sample type : tissue
Clinical method: immunohistochemistry
Expression pattern : upregulated
Biomarker characteristic: S 100protein-positive Langerhans cells
